Secondary Schizophrenia (144 page)

reports are available on the use of cholinesterase

Additionally, the efficacy and risks of neurophar-

inhibitors or memantine in FS or FD.

macologic and psychopharmacologic interventions in

For neurological symptoms, physiotherapy and

FD and the correlates of good and poor outcomes with
rehabilitation may be helpful. The response of parkin-these interventions remain to be defined
[11].
Given
sonian features to levodopa therapy is generally poor,
the substantial number of conditions associated with
possibly because the parkinsonism arises from post-

BGC, it is likely that more conditions will be identified
synaptic receptor site dysfunction and not decreased
in the future. The importance of distinguishing chance
dopamine turnover
[8].
A positive response to lev-associations from causal relationships should not be
odopa in limited cases has been attributed to the coex-underestimated. Future research may determine which
istence of IBGC and idiopathic Parkinson’s Disease

of these conditions cause FD
[2].

362

Chapter 29 – Fahr’s Disease and psychosis

References

10. Vles J. S. H., Lodder J., Van Der

19. Koller W. C., Cochran J. W.,

Lugt P. J. M. Clinical significance

Klawans H. L. Calcification of the

1. Manyam B. V., Walters A. S.,

of basal ganglia calcifications

basal ganglia: computerized

Narla K. R. Bilateral

detected by CT: A retrospective

tomography and clinical

striopallidodentate calcinosis:

study of 33 cases. Clin Neurol

correlation. Neurology, 1979.

clinical characteristics of patients

Neurosurg, 1981.
83
(4):253–6.

29
(3):328–33.

seen in a registry. Movement

Disord, 2001.
16
(2):258–64.

11. Lauterbach E. C., Cummings J. L.,

20. Pierri J. N., Lewis D. A. (2005).

Duffy J.,
et al.
Neuropsychiatric

Functional neuroanatomy. In

2. Lauterbach E. C. (2000). Fahr’s

correlates and treatment of

Kaplan and Sadock’s

syndrome. In Psychiatric

lenticulostriatal diseases: a review

Comprehensive Textbook of

Management in Neurological

of the literature and overview of

Psychiatry, Sadock B. J. and

Disease, Lauterbach E. C. (Ed.).

research opportunities in

Sadock V. A. (Eds.). Philadelphia:

Washington, DC: American

Huntington’s, Wilson’s, and Fahr’s

Lippincott Williams & Wilkins.

Psychiatric Publishing, Inc.,

diseases. A report of the ANPA

pp. 137–78.

21. Cummings J. L., Benson D. F.

Committee on Research.

Subcortical dementia. Review of

3. Manyam B. V. What is and what is

American Neuropsychiatric

an emerging concept. Arch

not ‘Fahr’s disease.’ Parkinsonism

Association. [See comment.]

Neurol, 1984.
41
(8):874–9.

Relat Disord, 2005.
11
(2):73–80.

J Neuropsych Clin Neurosci, 1998.

10
(3):249–66.

22. Bhimani S., Sarwar M.,

4. Chabot B., Roulland C., Dollfus S.

Virapongse C.,
et al.
Computed

Schizophrenia and familial

12. Harrington M. G., Macpherson P.,

tomography of cerebrovascular

idiopathic basal ganglia

McIntosh W. B.,
et al.
The

calcifications in postsurgical

calcification: a case report. Psychol

significance of the incidental

hypoparathyroidism. J Comput

Med, 2001.
31
(4):741–7.

finding of basal ganglia

Assist Tomogr, 1985.
9
(1):

calcification on computed

5. Brodaty H. M. P., Luscombe G.,

121–4.

tomography. J Neurol Neurosurg

Kwok J. B.,
et al.
Familial

Psychiatry, 1981.
44
(12):1168–70.

23. Sarwar M., Ford K. Rapid

idiopathic basal ganglia

development of basal ganglia

calcification (Fahr’s disease)

13. Kazis A. D. Contribution of CT

calcification. AJNR: Am J

without neurological, cognitive

scan to the diagnosis of Fahr’s

Neuroradiol, 1981.
2
(1):

and psychiatric symptoms is not

syndrome. Acta Neurol Scand,

103–4.

linked to the BGC1 locus on

1985.
71
(3):206–11.

24. Schultz W., Tremblay L.,

chromosome 14q. Hum Genet,

14. Konig P. Psychopathological

Hollerman J. R. Reward

2002.
110
:8–14.

alterations in cases of symmetrical

prediction in primate basal

6. Cohen C. R., Duchesneau P. M.,

basal ganglia sclerosis. Biol

ganglia and frontal cortex.

Weinstein M. A. Calcification of

Psychiatry, 1989.
25
(4):459–68.

Neuropharmacology, 1998.

the basal ganglia as visualized by

15. Murphy M. J. Clinical correlations

37
(4–5):421–9.

computed tomography. Radiology,

of CT scan-detected calcifications

25. Shakibai S., Johnson J., Bourgeois

1980.
134
(1):97–9.

of the basal ganglia. Ann Neurol,

J. Paranoid delusions and

7. Cummings J. L., Gosenfeld L. F.,

1979.
6
(6):507–11.

cognitive impairment suggesting

Houlihan J. P.,
et al.

16. Stellamor K., Stellamor V.

Fahr’s disease. Psychosomatics,

Neuropsychiatric disturbances

Roentgen diagnosis of Fahr’s

2005.
46
(6):569–72.

associated with idiopathic

disease. Rontgen-Blatter, 1983.

26. Aarsland D., Litvan I., Larsen J. P.

calcification of the basal ganglia.

36
(6):194–6.

Neuropsychiatric symptoms of

Biol Psychiatry, 1983.
18
(5):
17. Kobari M., Nogawa S., Sugimoto

patients with progressive

591–601.

Y.,
et al.
Familial idiopathic brain

supranuclear palsy and

8. Klawans H. L., Lupton M., Simon

calcification with autosomal

Parkinson’s disease. J Neuropsych

L. Calcification of the basal

dominant inheritance. Neurology,

Clin Neurosci, 2001.
13
(1):

ganglia as a cause of

1997.
48
(3):645–9.

42–9.

levodopa-resistant parkinsonism.

18. Forstl H., Krumm B., Eden S.,

27. Manyam B. V., Bhatt M. H.,

Neurology, 1976.
26
(3):221–5.

et al.
Neurological disorders in

Moore W. D.,
et al.
Bilateral

9. Ring H. A., Serra-Mestres J.

166 patients with basal ganglia

stiopallidodentate calcinosis:

Neuropsychiatry of the basal

calcification: a statistical

cerebrospinal fluid, imaging, and

ganglia. J Neurol Neurosurg

evaluation. J Neurol, 1992.

electrophysiological studies. Ann

Psychiatry, 2002.
72
(1):12–21.

239
(1):36–8.

Neurol, 1992.
31
:379–84.

363

Organic Syndromes of Schizophrenia – Section 3

28. Ellie E., Julien J., Ferrer X.

Holland Publishing Company,

calcification of basal ganglia

Familial idiopathic

pp. 703–25.

pathways. Bio Psychiatry, 1994.

striopallidodentate calcifications.

37. Casanova M. F., Araque J. M.

35
(5):345–51.

Neurology, 1989.
39
(3):381–5.

Mineralization of the basal

46. Rosenberg D. R., Neylan T. C.,

29. Flint J., Goldstein L. H. Familial

ganglia: implications for

el-Alwar M.,
et al.

calcification of the basal ganglia: a

neuropsychiatry, pathology and

Neuropsychiatric symptoms

case report and review of the

neuroimaging. Psychiatry Res,

associated with idiopathic

literature. Psychol Med, 1992.

2003.
121
(1):59–87.

calcification of the basal ganglia.

22
(3):581–95.

38. Duckett S., Galle P., Escourolle R.,

J Nerv Ment Dis, 1991.

30. Smits M. G., Gabreels F. J.,

et al.
Presence of zinc, aluminum,

179
(1):48–9.

Thijssen H. O.,
et al.
Progressive

magnesium in striopalledodentate

47. Wodarz N., Becker T., Deckert J.

idiopathic striopallido-dentate

(SPD) calcifications (Fahr’s

Musical hallucinations associated

calcinosis (Fahr’s disease) with

disease): electron probe study.

with post-thyroidectomy

autosomal recessive inheritance.

Acta Neuropathol, 1977.

hypoparathyroidism and

Report of three siblings. Eur

38
(1):7–10.

symmetric basal ganglia

Neurol, 1983.
22
(1):58–64.

39. Smeyers-Verbeke J., Michotte Y.,

calcifications. [See comment.]

J Neurol Neurosurg Psychiatry,

31. Geschwind D. H., Loginov M.,

Pelsmaeckers J.,
et al.
The

1995.
58
(6):763–4.

Stern J. M. Identification of a

chemical composition of

locus on chromosome 14q for

idiopathic nonarteriosclerotic

48. Hall P. Calcification of the basal

idiopathic basal ganglia

cerebral calcifications. Neurology,

ganglia apparently presenting as a

calcification (Fahr disease). Am J

1975.
25
(1):48–57.

schizophreniform psychosis.

Hum Genet, 1999.
65
(3):764–72.

40. Bouras C., Giannakopoulos P.,

Postgrad Med J, 1972.
48
:636–9.

32. Lowenthal A. (1986).

Good P. F.,
et al.
A laser

49. Fernandez-Bouzas A., Angrist B.,

Striopallidodentate calcifications.

microprobe mass analysis of trace

Hemdal P.,
et al.
Basal ganglia

In Handbook of Clinical

elements in brain mineralizations

calcification in schizophrenia. Biol

Neurology, Vol 5(49), Vinken P. J.

and capillaries in Fahr’s disease.

Psychiatry, 1990.
27
(6):682–5.

and Bruyn G. W. (Eds.).

Acta Neuropathol, 1996.

50. Brodaty H., Mitchell P., Luscombe

Amsterdam: John Wiley & Sons,

92
(4):351–7.

G.,
et al.
Familial idiopathic basal

Inc., pp. 417–36.

41. Beall S. S., Patten B. M., Mallette

ganglia calcification (Fahr’s

33. Adachi M., Wellmann K. F., Volk

L.,
et al.
Abnormal systemic

disease) without neurological,

B. W. Histochemical studies on

metabolism of iron, porphyrin,

cognitive and psychiatric

the pathogenesis of “idiopathic

and calcium in Fahr’s syndrome.

symptoms is not linked to the

nonarteriosclerotic cerebral

Ann Neurol, 1989.
26
(4):569–75.

IBGC1 locus on chromosome

calcification.” J Neuropathol Exper

42. Kobayashi S., Yamadori I., Miki

14q. Hum Genet, 2002.
110
:8–14.

Neurol, 1968.
27
(1):153–4.

H.,
et al.
Idiopathic

51. Lopez-Villegas D., Kulisevsky J.,

34. Friede R. L., Magee K. R., Mack E.

nonarteriosclerotic cerebral

Deus J.,
et al.
Neuropsychological

W. Idiopathic nonarteriosclerotic

calcification (Fahr’s disease): an